Trial Search Results

Overcoming Barriers and Obstacles to Adopting Diabetes Devices (ONBOARD) Trial

This study is a comprehensive, multicomponent behavioral intervention package (ONBOARD; OvercomiNg Barriers & Obstacles to Adopting Diabetes Devices). ONBOARD will provide adults with T1D the skills to maximize benefit and minimize daily interference from barriers associated with Continuous Glucose Monitoring (CGM) and increase readiness for closed loop.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Molly Tanenbaum

Collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Stanford Investigator(s):


  • Behavioral: ONBOARD




Inclusion Criteria:

   1. Subject is age 18-50 years at time of enrollment

   2. Subject must not have been using CGM regularly for past 6 months

   3. Subject has a clinical diagnosis of type 1 diabetes

   4. Subject comprehends spoken and written English

Exclusion Criteria:

   1. Subject has a medical disorder that in the judgment of the investigator will interfere
   with completion of any aspect of the protocol.

   2. Subject has a neurologic disorder that in the judgment of the investigator will affect
   completion of the protocol.

Ages Eligible for Study

18 Years - 50 Years

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Molly Tanenbaum, PhD